Alfasigma: Alfasigma Signs an Agreement with Galapagos to Buy Jyseleca Drug Assets

Alfasigma spa, a Bologna-based pharmaceutical company and one of the leading ones in Italy, announced the signing of a letter of intent to acquire the entire Jyseleca drug business from Galapagos, a global biotechnology company based in Belgium. Galapagos develops innovative drugs in oncology and immunology, listed on both Euronext Amsterdam and Nasdaq. If you [...]